SYHLF yields 0.85% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 8
Combined, SYHLF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SYHLF + PFE for your $10,000?
Symphony Holdings Limited, an investment holding company, primarily operates as a retailing company. It operates through Branding, Retailing, and Financial Services segments. The company is involved in the retailing and provision of sourcing services for branded apparel, swimwear, and accessories; manufacturing and trading of healthcare products; and development and management of PONY and SKINS trademarks. It also manages and operates outlet malls, duty free shops, and fashion stores; and provides securities brokerage, margin financing, underwriting and placing, financial consulting, and money lending services. In addition, the company offers information, technology, corporate, and portfolio management services; accountancy, legal, secretarial, and cruiser services; and online trading platform support services. Further, it engages in the trading, retailing, and distribution of swimming apparel and accessories; property investment and holding activities; holding of club debentures; sub-licensing of trademark rights; and trading and wholesaling of sportswear. It operates in the People's Republic of China, Hong Kong, other Asian countries, the United States, the United Kingdom, and internationally. The company was formerly known as Liang Shing (Holdings) Limited and changed its name to Symphony Holdings Limited in 1997. Symphony Holdings Limited was incorporated in 1993 and is based in North Point, Hong Kong.
Full SYHLF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.